| Dr Alfred J Mauriello Ii, MD | |
|
15 Industrial Blvd, Ste 102, Paoli, PA 19301-1608 | |
| (610) 363-2532 | |
| (610) 363-0210 |
| Full Name | Dr Alfred J Mauriello Ii |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology - Otolaryngology/facial Plastic Surgery |
| Location | 15 Industrial Blvd, Paoli, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144218793 | NPI | - | NPPES |
| 0006068850001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | MD011731E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alfred J Mauriello Ii, MD 15 Industrial Blvd, Ste 102, Paoli, PA 19301-1608 Ph: (610) 363-2532 | Dr Alfred J Mauriello Ii, MD 15 Industrial Blvd, Ste 102, Paoli, PA 19301-1608 Ph: (610) 363-2532 |
News Archive
People with Parkinson's disease have significantly higher blood levels of a particular pesticide than healthy people or those with Alzheimer's disease, researchers at UT Southwestern Medical Center have found.
Researchers have invented a technique that uses inexpensive paper to make "microfluidic" devices for rapid medical diagnostics and chemical analysis.
Mutations from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have created multiple variants. Some variants, such as those found in South Africa and Brazil, have caused concern for their potential to evade the immune response. While vaccination efforts are underway, the world is racing against the viruses' ability to evolve under selective pressure.
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, today announced that it has entered into an agreement with Mirna Therapeutics Inc., a biopharmaceutical company pioneering microRNA-based therapeutics for cancer, to assess the delivery capabilities of Silence's proprietary AtuPLEX and DBTC delivery systems for Mirna's novel microRNAs.
Even as California prepares to expand vaccine eligibility on April 15 to all residents age 16 and up, the state has managed to inoculate only about half its senior population — the 65-and-older target group deemed most vulnerable to death and serious illness in the pandemic.
› Verified 4 days ago
Charles Stroud Gawthrop Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 11 Industrial Blvd, Ste 102, Paoli, PA 19301 Phone: 215-662-2137 | |
Lawrence I Katin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 11 Industrial Blvd, Ste 102, Paoli, PA 19301 Phone: 610-647-6070 Fax: 610-647-6851 |